{"entity":{"id":"nct05699746","kind":"trial","name":"CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD","aka":[],"tldr":"A phase 3 trial of capecitabine and fOLFOX (5-FU, leucovorin, oxaliplatin) in colorectal cancer, run by Zhejiang University, not yet recruiting.","summary":"CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD is a phase 3, randomised interventional study registered as NCT05699746 by Zhejiang University, with a registry enrolment figure of 38 participants, started 2023-03 and due to reach its primary completion in 2026-09. Interventions recorded: Capecitabine tablets; Oxaliplatin. Conditions listed: Colorectal Cancer. Primary outcome: Recurrence-free survival. Colorectal eligibility wording from the registry: \"Colorectal cancer confirmed by pathology, and the TNM stage (AJCC v8) is stage I or stage II\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05699746","url":"https://clinicaltrials.gov/study/NCT05699746"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":["cytotoxic-chemotherapy","platinum"],"targets":[],"drugs":["capecitabine","folfox"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05699746","phase":"3","setting":"A Randomized Controlled Trial of CAPEOX vs Observation in Early-stage Colorectal Cancer Patients With Positive MRD After Curative Surgery","sponsor":"Zhejiang University","enrolled":38,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05699746/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"},{"id":"platinum","kind":"technology","name":"Platinum agents","route":"/technologies/platinum/"}],"drug":[{"id":"capecitabine","kind":"drug","name":"Capecitabine","route":"/drugs/capecitabine/"},{"id":"folfox","kind":"drug","name":"FOLFOX (5-FU, leucovorin, oxaliplatin)","route":"/drugs/folfox/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}